Assignee
POVIVA CORP
US·14 granted patents·17 pending applications·39 citations·filing 2018–2025
Top patents by PatentIndex Score
31 records- 0196US11666544B1Compositions and methods for treating hypertensionPOVIVA CORP·Filed 2022·Granted Jun 6, 2023·13 cites·18 claims
- 0296US11666543B1Pharmaceutical compositions and methods for treating hypertensionPOVIVA CORP·Filed 2022·Granted Jun 6, 2023·13 cites·16 claims
- 0395US11944635B1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2023·Granted Apr 2, 2024·4 cites·29 claims
- 0493US12220422B1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2024·Granted Feb 11, 2025·1 cites·30 claims
- 0593US12213986B1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2024·Granted Feb 4, 2025·1 cites·24 claims
- 0693US12023346B1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2023·Granted Jul 2, 2024·2 cites·13 claims
- 0791US11986485B1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2023·Granted May 21, 2024·1 cites·22 claims
- 0891US11931369B1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2023·Granted Mar 19, 2024·1 cites·12 claims
- 0988US12472236B2Compositions and methods for treating diabetesPOVIVA CORP·Filed 2024·Granted Nov 18, 2025·0 cites·18 claims
- 1088US12397042B2Compositions and methods for treating diabetesPOVIVA CORP·Filed 2024·Granted Aug 26, 2025·0 cites·11 claims
- 1187US10756180B2Food and beverage compositions infused with lipophilic active agents and methods of use thereofPOVIVA CORP·Filed 2019·Granted Aug 25, 2020·2 cites·20 claims
- 1287US2026041737A1Compositions and methods for treating diabetesPOVIVA CORP·Filed 2025·Application pending·0 cites
- 1386US11311559B2Compositions and methods for enhanced delivery of antiviral agentsPOVIVA CORP·Filed 2021·Granted Apr 26, 2022·1 cites·21 claims
- 1484US2024226033A1Compositions and methods for treating hypertensionPOVIVA CORP·Filed 2024·Application pending·0 cites
- 1583US2025352623A1Compositions and methods for treating diabetesPOVIVA CORP·Filed 2025·Application pending·0 cites
- 1673US11980593B2Compositions and methods for treating hypertensionPOVIVA CORP·Filed 2022·Granted May 14, 2024·0 cites·20 claims
- 1769US2021235716A1Stable ready-to-drink beverage compositions comprising lipophilic active agentsPOVIVA CORP·Filed 2021·Application pending·0 cites
- 1869US2025161333A1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2025·Application pending·0 cites
- 1966US11700875B1Compositions and methods for sublingual delivery of nicotinePOVIVA CORP·Filed 2022·Granted Jul 18, 2023·0 cites·30 claims
- 2066US2021177978A1Methods for formulating orally ingestible compositions comprising lipophilic active agentsPOVIVA CORP·Filed 2021·Application pending·0 cites
- 2164US2025032516A1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2023·Application pending·0 cites
- 2264US2025387416A1Compositions and methods for treating diabetesPOVIVA CORP·Filed 2024·Application pending·0 cites
- 2363US2023301341A1Compositions and methods for sublingual delivery of nicotinePOVIVA CORP·Filed 2022·Application pending·0 cites
- 2460US2024009140A1Pharmaceutical compositions and methods for treating hypertensionPOVIVA CORP·Filed 2022·Application pending·0 cites
- 2560US2026053894A1Compositions and methods for treating diabetesPOVIVA CORP·Filed 2025·Application pending·0 cites
- 2654US2021213091A1Lipophilic active agent infused tobacco leaves and/or tobacco materials and methods of use thereofPOVIVA CORP·Filed 2021·Application pending·0 cites
- 2751US2023094827A1Nanoemulsion compositions comprising biologically active ingredientsPOVIVA CORP·Filed 2020·Application pending·0 cites
- 2851US2021145841A1Enhancement of delivery of lipophilic active agents across the blood-brain barrier and methods for treating central nervous system disordersPOVIVA CORP·Filed 2019·Application pending·0 cites
- 2951US2022160731A1Compositions comprising biologically active agents and bile saltsPOVIVA CORP·Filed 2020·Application pending·0 cites
- 3050US2021045998A1Transdermal and/or dermal delivery of lipophilic active agentsPOVIVA CORP·Filed 2019·Application pending·0 cites
- 3149US2020323773A1Food and beverage compositions comprising pde5 inhibitorsPOVIVA CORP·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when POVIVA CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →